ADMA Biologics, Inc. (ADMA)
9.545
-0.30
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Price : 9.545 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 9.77 | 9.95 | 9.68 | 9.84 | 1.477M |
| Aug 20, 2026 | 9.98 | 10.08 | 9.695 | 9.76 | 2.193M |
| Aug 19, 2026 | 9.76 | 10.12 | 9.70 | 10.05 | 2.689M |
| Aug 18, 2026 | 9.35 | 9.579 | 9.335 | 9.54 | 1.370M |
| Aug 17, 2026 | 9.51 | 9.60 | 9.315 | 9.34 | 1.497M |
| Aug 14, 2026 | 9.47 | 9.49 | 9.33 | 9.47 | 1.309M |
| Aug 13, 2026 | 9.85 | 9.865 | 9.24 | 9.41 | 3.107M |
| Aug 12, 2026 | 9.83 | 9.96 | 9.755 | 9.78 | 1.919M |
| Aug 11, 2026 | 9.875 | 10.01 | 9.73 | 9.905 | 2.539M |
| Aug 10, 2026 | 9.79 | 10.06 | 9.705 | 9.75 | 1.899M |
| Aug 07, 2026 | 9.97 | 10.18 | 9.75 | 9.90 | 3.305M |
| Aug 06, 2026 | 9.70 | 10.35 | 9.66 | 10.06 | 5.616M |
| Aug 05, 2026 | 9.00 | 9.32 | 8.94 | 9.26 | 3.800M |
| Aug 04, 2026 | 8.69 | 9.02 | 8.66 | 8.91 | 2.820M |
| Aug 03, 2026 | 8.635 | 8.87 | 8.57 | 8.74 | 2.573M |
| Jul 31, 2026 | 8.58 | 8.66 | 8.35 | 8.46 | 1.620M |
| Jul 30, 2026 | 8.51 | 8.74 | 8.48 | 8.67 | 1.304M |
| Jul 29, 2026 | 8.71 | 8.875 | 8.60 | 8.71 | 2.185M |
| Jul 28, 2026 | 8.57 | 8.795 | 8.495 | 8.79 | 2.172M |
| Jul 27, 2026 | 8.38 | 8.62 | 8.35 | 8.48 | 2.389M |
| Jul 24, 2026 | 8.40 | 8.47 | 8.165 | 8.27 | 2.341M |
| Jul 23, 2026 | 8.36 | 8.40 | 8.19 | 8.37 | 2.617M |
| Jul 22, 2026 | 8.59 | 8.68 | 8.323 | 8.38 | 1.986M |
| Jul 21, 2026 | 8.685 | 8.755 | 8.58 | 8.59 | 2.579M |
| Jul 20, 2026 | 8.75 | 8.825 | 8.54 | 8.75 | 2.487M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Erasca, Inc. | 17.61 |
| Krystal Biotech, Inc. | 341.78 |
| Vericel Corp. | 42.36 |
| Emergent BioSolutions, Inc. | 5.17 |
| Exelixis, Inc. | 54.57 |
Price Related Metrics
| PE Ratio | 13.55 |
| PS Ratio | 4.466 |
| Price to Book Value | 5.269 |
| Price to Free Cash Flow | 19.69 |
| Earnings Yield | 7.38% |
| Market Cap | 2.151B |
| Operating PE Ratio | 10.57 |
| Normalized PE Ratio | 13.43 |